Topics & People

A neurodegenerative disorder that could potentially be treated by mitochondrial therapy.

A developing therapy aimed at restoring the energy-producing function of cells using young donor mitochondria.

A mental disorder that could be triggered in predisposed individuals by psychedelics.

A severe mental condition that is a potential risk of using high-dose psychedelics.

A test that detects electrical activity in the brain, used to quantify the effects of psychedelics.

Magnetic resonance imaging used to map structural and functional brain changes.

A dissociative anesthetic used as a therapy for depression, previously studied extensively by Kernel.

Blood sugar levels that experienced a profound metabolic reset after psychedelic therapy.

A biological response targeted by longevity therapies because it drives aging and disease.

The brain's ability to rewire itself and form new neural connections, stimulated by psychedelics.

A brain interface company founded by Bryan Johnson that maps brain activity and connectivity.

A brain network associated with ego and rumination that becomes rigid with age and is suppressed by psychedelics.